Sharps Compliance (NASDAQ:SMED) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $18.90 million which beat the analyst consensus estimate of $17.99 million by 5.06 percent. This is a 11.10 percent increase over sales of $17.01 million the same period last year.
This Women Health Stock Gets Analyst Downgrade On ‘Approvability Issues, Restructuring’
HC Wainwright has downgraded ObsEva SA (NASDAQ:OBSV) from a Buy to Neutral without a price target. Late last month, the FDA notified…
